Idiopathic Pulmonary Fibrosis Clinical Trial Using Cotrimoxazole and Placebo

- The folks at Fundaci¢n P£blica Andaluza para la gesti¢n de la Investigaci¢n en Sevilla are studying the effects of Cotrimoxazole; Placebo on Idiopathic Pulmonary Fibrosis in individuals ages 18 years to 80 years. This clinical trial is slated to start June 2013 and is expected to end circa December 2014.

Francisco J. Medrano Ortega, PhD
Overall Study Contact Info
StatusName Contact Phone
RecruitingFrancisco J. Medrano Ortega, PhDmedrano@cica.es

This study is officially titled, "Pilot Study Phase III to Evaluate the Efficacy and Safety of Trimethoprim-sulfamethoxazole in the Treatment of Idiopathic Pulmonary Fibrosis."

Locations

Hospital Universitario Virgen del Roc¡o/ Instituto de Biomedicina de Sevilla

Sevilla, Spain - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.